Clinical TrialsAstraZeneca Reports Early Proteinuria Reduction With Ultomiris in IgAN Tria... AstraZeneca Reports Early Proteinuria Reduction With Ultomiris in IgAN Tria... Read Post »
New Drug ApprovalEU Authorizes Moderna’s mCOMBRIAX for Influenza and COVID-19 in Adults 50... EU Authorizes Moderna’s mCOMBRIAX for Influenza and COVID-19 in Adults 50... Read Post »
New Drug ApprovalBlenrep Gains China Approval for Relapsed/Refractory Multiple Myeloma Blenrep Gains China Approval for Relapsed/Refractory Multiple Myeloma Read Post »
Clinical TrialsBicycle Therapeutics Highlights Nuzefatide Progress in Pancreatic Cancer Bicycle Therapeutics Highlights Nuzefatide Progress in Pancreatic Cancer Read Post »
Clinical TrialsLundbeck Highlights Brain Fog Improvements with Eptinezumab Lundbeck Highlights Brain Fog Improvements with Eptinezumab Read Post »
Clinical TrialsAstraZeneca Reports Positive MIRANDA Trial Results for Tozorakimab in COPD AstraZeneca Reports Positive MIRANDA Trial Results for Tozorakimab in COPD Read Post »
Clinical TrialsNew data from United Therapeutics points to earlier action in pulmonary hyp... New data from United Therapeutics points to earlier action in pulmonary hyp... Read Post »
Clinical TrialsXenon Presents Positive X-TOLE2 Results Supporting Azetukalner in Epilepsy Xenon Presents Positive X-TOLE2 Results Supporting Azetukalner in Epilepsy Read Post »
Clinical TrialsNovo Nordisk Delivers a New Pulse in Sickle Cell Care with Etavopivat Novo Nordisk Delivers a New Pulse in Sickle Cell Care with Etavopivat Read Post »
ResearchZai Lab Highlights Long-Lasting Reduction in Pruritus and Inflammation with... Zai Lab Highlights Long-Lasting Reduction in Pruritus and Inflammation with... Read Post »
ResearchWhat Is the Optimal Time to Take Statins: Morning or Evening? What Is the Optimal Time to Take Statins: Morning or Evening? Read Post »
Clinical TrialsSanofi’s COVID-19 Vaccine Nuvaxovid Demonstrates Superior Tolerability vs... Sanofi’s COVID-19 Vaccine Nuvaxovid Demonstrates Superior Tolerability vs... Read Post »
Clinical TrialsModerna’s mRNA-4359 Opens a New Front in the Fight Against Advanced Melan... Moderna’s mRNA-4359 Opens a New Front in the Fight Against Advanced Melan... Read Post »
New Drug ApprovalShifting the Treatment Ground: NICE Endorses Oral Pirtobrutinib for CLL Shifting the Treatment Ground: NICE Endorses Oral Pirtobrutinib for CLL Read Post »
Clinical TrialsZai Lab’s Zocilurtatug Pelitecan Shows Strong Intracranial Responses in E... Zai Lab’s Zocilurtatug Pelitecan Shows Strong Intracranial Responses in E... Read Post »
Clinical TrialsNuvalent’s Zidesamtinib Demonstrates Strong Activity in Pretreated ROS1+ ... Nuvalent’s Zidesamtinib Demonstrates Strong Activity in Pretreated ROS1+ ... Read Post »
Clinical TrialsGigaGen Reports Early Phase 1 Data for GIGA-564 in Advanced Solid Tumors at... GigaGen Reports Early Phase 1 Data for GIGA-564 in Advanced Solid Tumors at... Read Post »
Clinical TrialsRoche advances Elevidys with planned Phase III study to support EMA resubmi... Roche advances Elevidys with planned Phase III study to support EMA resubmi... Read Post »
New Drug ApprovalEC Approves ENFLONSIA for RSV Prevention in Infants Across Europe EC Approves ENFLONSIA for RSV Prevention in Infants Across Europe Read Post »
New Drug ApprovalNICE Backs Belantamab Mafodotin for Relapsed Multiple Myeloma in NHS NICE Backs Belantamab Mafodotin for Relapsed Multiple Myeloma in NHS Read Post »
Clinical TrialsLilly Bolsters Foundayo’s Case with ACHIEVE-4 Data Under FDA Scrutiny Lilly Bolsters Foundayo’s Case with ACHIEVE-4 Data Under FDA Scrutiny Read Post »
Clinical TrialsTurning the Tap Back On: MeiraGTx’s AAV-hAQP1 Delivers Three-Year Durabil... Turning the Tap Back On: MeiraGTx’s AAV-hAQP1 Delivers Three-Year Durabil... Read Post »
Clinical TrialsBayer Advances a Safer Clot Strategy as Asundexian Lowers Stroke Risk by 26... Bayer Advances a Safer Clot Strategy as Asundexian Lowers Stroke Risk by 26... Read Post »
Clinical TrialsAicuris Advances Pritelivir with Priority Review and Strong Phase 3 Data Aicuris Advances Pritelivir with Priority Review and Strong Phase 3 Data Read Post »
New Drug ApprovalFDA Clears Expanded Use of Caldolor for Postoperative Pain Treatment FDA Clears Expanded Use of Caldolor for Postoperative Pain Treatment Read Post »
Drugs Safety AlertFDA Requires Extensive Postmarketing Safety Data for Foundayo FDA Requires Extensive Postmarketing Safety Data for Foundayo Read Post »
Clinical TrialsAstellas Ignites a New Front in KRAS G12D Battle with Phase 3 Entry of Seti... Astellas Ignites a New Front in KRAS G12D Battle with Phase 3 Entry of Seti... Read Post »
Clinical TrialsINGREZZA Secures the Long Game as AUSTEDO XR Lags in Treatment Persistence INGREZZA Secures the Long Game as AUSTEDO XR Lags in Treatment Persistence Read Post »
Clinical TrialsAligos Maps a Wider HBV Horizon as Pevifoscorvir Gains Ground in Phase 2 Aligos Maps a Wider HBV Horizon as Pevifoscorvir Gains Ground in Phase 2 Read Post »
Clinical TrialsDaraxonrasib Ignites a Survival Breakthrough in Pancreatic Cancer’s Tough... Daraxonrasib Ignites a Survival Breakthrough in Pancreatic Cancer’s Tough... Read Post »
Clinical TrialsSpyre’s SPY001 Pushes the Boundary of UC Care with Promising Induction Re... Spyre’s SPY001 Pushes the Boundary of UC Care with Promising Induction Re... Read Post »
Clinical TrialsIDEAYA and Servier Anchor Darovasertib Combo in Metastatic Uveal Melanoma IDEAYA and Servier Anchor Darovasertib Combo in Metastatic Uveal Melanoma Read Post »
Clinical TrialsEmactuzumab Breaks the Cycle of Chronic Therapy in TGCT with Phase 3 Result... Emactuzumab Breaks the Cycle of Chronic Therapy in TGCT with Phase 3 Result... Read Post »
Clinical TrialsAllogene Brings CAR T to the Frontline Edge, ALPHA3 Shows Early MRD Win Allogene Brings CAR T to the Frontline Edge, ALPHA3 Shows Early MRD Win Read Post »
New Drug ApprovalFILSPARI Unlocks the Door for FSGS With First FDA Approval FILSPARI Unlocks the Door for FSGS With First FDA Approval Read Post »
Clinical TrialsOcular Therapeutix Shows Durable Wet AMD Control With AXPAXLI Ocular Therapeutix Shows Durable Wet AMD Control With AXPAXLI Read Post »
New Drug ApprovalDupixent Extends Its Reach to Young CSU Patients in EU Dupixent Extends Its Reach to Young CSU Patients in EU Read Post »
Clinical TrialsAbbVie’s ELAHERE Combo Drives a Targeted Assault on FRα-Positive Tumors AbbVie’s ELAHERE Combo Drives a Targeted Assault on FRα-Positive Tumors Read Post »
Clinical TrialsGSK’s Mo-Rez Breaks Through in BEHOLD-1 With Strong Early Responses GSK’s Mo-Rez Breaks Through in BEHOLD-1 With Strong Early Responses Read Post »
ResearchSemaglutide Slows the Spiral of Worsening Mental Illness Semaglutide Slows the Spiral of Worsening Mental Illness Read Post »
Clinical TrialsKainova Starts Europe Dosing for DT-7012 in DOMISOL Trial Kainova Starts Europe Dosing for DT-7012 in DOMISOL Trial Read Post »
New Drug ApprovalMHRA Unleashes Tryngolza to Break the Triglyceride Surge in FCS MHRA Unleashes Tryngolza to Break the Triglyceride Surge in FCS Read Post »
Clinical TrialsCorcept Delivers Survival Benefit With Relacorilant in Phase 3 ROSELLA Corcept Delivers Survival Benefit With Relacorilant in Phase 3 ROSELLA Read Post »
Drugs Safety AlertOntozry Gets EMA Liver Safety Warning Ontozry Gets EMA Liver Safety Warning Read Post »
Clinical TrialsBioNTech–DualityBio ADC Delivers Across HER2 Levels in Endometrial Cancer BioNTech–DualityBio ADC Delivers Across HER2 Levels in Endometrial Cancer Read Post »
Drugs Safety AlertMifepristone Lawsuits Paused as Court Waits for FDA Safety Review Mifepristone Lawsuits Paused as Court Waits for FDA Safety Review Read Post »
Clinical TrialsFDA Permits Direct Shift of Ryoncil from IND Stage to Registrational Study FDA Permits Direct Shift of Ryoncil from IND Stage to Registrational Study Read Post »
Clinical TrialsMilestone Opens Real-World Chapter for CARDAMYST With RESET-PSVT Milestone Opens Real-World Chapter for CARDAMYST With RESET-PSVT Read Post »
Clinical TrialsPREVAIL and KOMET Readouts Set Stage for Alexion at AAN 2026 PREVAIL and KOMET Readouts Set Stage for Alexion at AAN 2026 Read Post »
ResearchHow Novartis Is Expanding Community Health Programs Globally? How Novartis Is Expanding Community Health Programs Globally? Read Post »
